Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Viruses Year : 2013

Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.

Abstract

Hepatitis C virus (HCV) is a leading cause of chronic liver disease, including chronic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Hepatitis C infection associates with lipid and lipoprotein metabolism disorders such as hepatic steatosis, hypobetalipoproteinemia, and hypocholesterolemia. Furthermore, virus production is dependent on hepatic very-low-density lipoprotein (VLDL) assembly, and circulating virions are physically associated with lipoproteins in complexes termed lipoviral particles. Evidence has indicated several functional roles for the formation of these complexes, including co-opting of lipoprotein receptors for attachment and entry, concealing epitopes to facilitate immune escape, and hijacking host factors for HCV maturation and secretion. Here, we review the evidence surrounding pathogenesis of the hepatitis C infection regarding lipoprotein engagement, cholesterol and triglyceride regulation, and the molecular mechanisms underlying these effects.
Fichier principal
Vignette du fichier
viruses-05-01292.pdf (620.9 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-00850889 , version 1 (09-08-2013)

Identifiers

Cite

Daniel J. Felmlee, Mohamed Lamine Hafirassou, Mathieu Lefevre, Thomas F. Baumert, Catherine Schuster. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.. Viruses, 2013, 5 (5), pp.1292-324. ⟨10.3390/v5051292⟩. ⟨inserm-00850889⟩
79 View
383 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More